BioCardia (BCDA) announced the commercial availability of its Morph DNA steerable introducer product family, currently utilized in the Company’s ongoing cell-therapy clinical trials. “Our team is ...
The US National Institute of Standards and Technology (NIST) has published new guidelines it claims will help organizations optimize their efforts to detect face morphing software. Face morphing is a ...
SUNNYVALE, Calif., Dec. 17, 2024 (GLOBE NEWSWIRE) -- BioCardia, Inc. (BCDA) [Nasdaq: BCDA], a global leader in cellular and cell-derived therapeutics for the treatment of cardiovascular and pulmonary ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback